Registry for understanding heart failure in patients
Official title: The Türkiye Heart Failure (TURK-HF) Registry
Run by Baskent University · NCT06707220 · Data updated 2026-11-12
This study is creating a detailed registry to help understand heart failure in patients so we can find better ways to treat it and improve their health outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Baskent University Academic / other |
| Locations | 1 site (Ankara, Ankara) |
| Status | Recruiting |
| Started | January 8, 2025 |
| Main results expected | January 2027 |
| Study ends | December 2027 |
| Registry record updated | March 3, 2025 |
| Trial ID | NCT06707220 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years and older who have been diagnosed with heart failure.
✕Probably not a fit
Patients under 18 years of age will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a comprehensive registry that captures the socio-demographic, clinical, and biological characteristics of patients with heart failure. By identifying barriers to the implementation of guideline-directed medical therapies, the study seeks to improve patient outcomes and reduce hospitalization and mortality rates associated with heart failure. The registry will include patients with various forms of heart failure, including de novo, chronic, and worsening conditions, across different ejection fraction categories. The data collected will help inform strategies for better management and treatment of heart failure in real-world settings.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better outcomes for patients with heart failure.
How similar studies have gone: Other heart failure registries have shown success in improving patient outcomes by identifying barriers to treatment and enhancing guideline adherence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Presence of heart failure - Exclusion Criteria: Age \<18 years \-
Where it's running
-
Baskent University
Ankara, Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Umut Kocabaş
- Email: umutkocabas@hotmail.com
- Phone: +905079974999
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.